News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

CareFusion Expands Pyxis® Perioperative Solutions Offering
07/20/2009

Company unveils new products and services to improve supply management and streamline workflow at the 47th Annual AHRMM Conference

SAN DIEGO, July 20, 2009 — CareFusion Corporation, the company that will become publicly traded following the planned spinoff of the clinical and medical products businesses of Cardinal Health, today announced it has expanded its Pyxis® perioperative offerings that integrate with leading operating room information systems (ORIS), incorporate radio-frequency identification (RFID) technology1 and include new services.

“Our Pyxis® Perioperative Solutions provide hospitals with the technology and services necessary to help improve financial performance, increase operational efficiency and ensure regulatory compliance across both their perioperative and medical-surgical areas,” said Rusty Frantz, general manager of Pyxis® Perioperative Solutions for CareFusion.  “By integrating our industry leading supply management platform with leading perioperative information systems and providing the value-added services that help enable our customers to achieve best practice, we are delivering a solution that can provide tremendous benefit across the hospital and healthcare system.”

First-of-its-kind ORIS integration solution for improved workflow
By integrating Pyxis ProcedureStation™ system with a hospital’s ORIS, CareFusion helps streamline workflow and improve revenue cycle management.  The new offering automatically incorporates surgical supply information directly into patient records and increases preference card and case pick/costing accuracy, freeing nurses to spend less time on non-clinical activities and more time with patients. CareFusion’s perioperative integration partners include Picis®, Surgical Information Systems (SIS), Epic, and others.

“By integrating our Pyxis ProcedureStation™ system and Picis OR Manager at Beaufort Memorial Hospital, overall implant charting time was reduced by an average of 57% – saving OR nurses up to 1,000 clinician documentation hours annually,” said Frantz said.

CareFusion is actively pursuing additional clinical information system partnerships to leverage the capabilities of CareFusion products and services that help hospitals measurably improve the safety and quality of healthcare.

Advancing supply automation
By combining the benefits of the Pyxis ProcedureStation™ with RFID technology1, the Pyxis ProcedureStation™ RFID system from CareFusion helps hospitals manage high value supplies and streamlines clinician workflow while improving inventory accuracy and security. By providing an automated single point-of-access for dispensing of high value inventory, hospital staff can experience increased efficiency in take/return and item tracking, improved data capture and accuracy, the ability to manage expiration dates and recalls, and a reduction in inventory shrinkage.

Identifying process improvement opportunities
Focusing on back-end processes that are key to operational efficiency, CareFusion is introducing an array of service offerings designed to minimize process waste and maximize value. Item Master Preparation and Maintenance services help verify and establish data integrity, standardization and categorization within hospital Item Master systems.  Validity of data sets, such as populated and accurate distributor and manufacturer names, are crucial to the optimal performance of Pyxis® supply technologies and successful supply management.

Value Stream Mapping services guide hospitals through Lean transformation by helping them identify inefficiencies in their current processes, material and information flows. CareFusion’s expertise in Lean Six Sigma principles helps hospitals visualize where improvement opportunities exist and then analyze how to apply best practice methodology to reduce inefficiencies in specific areas or throughout the hospital. End results can include improved clinical workflow, increased revenue potential and the facilitation of regulatory compliance.

AHRMM09 highlights
CareFusion plans to highlight these and other key workflow enhancement and supply management solutions at the Association for Healthcare Resource & Materials Management’s (AHRMM09) 47th Annual Conference and Exhibition, in Tampa Bay, Florida, from July 19-22, 2009.

Key Pyxis® Perioperative Solution offerings CareFusion is highlighting at AHRMM09, Booth#401, include:

  • Pyxis ProcedureStation™ system with ORIS Integration
  • Pyxis ProcedureStation™ RFID system1
  • Pyxis ProcedureStation™ system with Tissue and Implant module
  • Pyxis SupplyStation® system with Biomet DME solution
  • Pyxis® StockStation™ system
  • Pyxis® JITrBUD system with Ergotron mobile cart solution
  • Pyxis SupplyRoller® system
  • Pyxis® ParAssist™ system<
  • Supply Performance Dashboard and Pyxis® SupplyCenter server
  • Item Master and Value Stream Mapping services


About CareFusion Corporation
CareFusion Corporation, a wholly owned subsidiary of Cardinal Health (NYSE:CAH), is expected to become a public company with the planned spinoff of the clinical and medical products businesses of Cardinal Health. The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of healthcare. CareFusion develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA and Pulmonetic Systems™ ventilation and respiratory products, ChloraPrep® for infection prevention and MedMined™ services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller® surgical instruments and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations. The company has applied to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol “CFN.”  More information may be found at carefusion.com.



1 Limited Commercial Release: CareFusion may not make this product available for commercial sale.


Cautions concerning forward-looking statements
This news release contains forward-looking statements addressing the planned spinoff of the clinical and medical products businesses of Cardinal Health as a separate company named CareFusion Corporation, which is dependent upon future events or developments.  These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied.  These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of any such spinoff and whether such spinoff will be completed as it is subject to a number of conditions.  In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion’s Form 10, as amended, and Cardinal Health’s Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports.  Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.

More Company News
11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

11/05/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on...

11/01/2024

Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating earnings were $568 million; GAAP...

View all company news »